PE20211268A1 - Proceso para preparar el benzotiofen-2-il boronato - Google Patents
Proceso para preparar el benzotiofen-2-il boronatoInfo
- Publication number
- PE20211268A1 PE20211268A1 PE2020000736A PE2020000736A PE20211268A1 PE 20211268 A1 PE20211268 A1 PE 20211268A1 PE 2020000736 A PE2020000736 A PE 2020000736A PE 2020000736 A PE2020000736 A PE 2020000736A PE 20211268 A1 PE20211268 A1 PE 20211268A1
- Authority
- PE
- Peru
- Prior art keywords
- benzothiophen
- boronate
- prepare
- methyl
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 7 -methoxy-5-methyl-1-benzothiophen-2-yl Chemical group 0.000 abstract 1
- YGHQIMOWWMQFLG-UHFFFAOYSA-N OBOC1=CC2=C(S1)C=CC=C2 Chemical compound OBOC1=CC2=C(S1)C=CC=C2 YGHQIMOWWMQFLG-UHFFFAOYSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un proceso eficaz con alto rendimiento para preparar el benzotiofen-2-il boronato de la formula (VI) que sirve como intermediario para la produccion de compuestos como la 4-{[4-Amino-6-(metoximetil)-5-(7-metoxi-5-metil-1-benzotiofen-2-il)pirrol[2,1 f]- [1,2,4]-triazin-7-il]metil}piperazin-2-ona. Estos compuestos se emplean en el tratamiento y/o la profilaxis de trastornos proliferativos, como, por ejemplo, cancer y enfermedades tumorales.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17198336 | 2017-10-25 | ||
| PCT/EP2018/078586 WO2019081346A1 (en) | 2017-10-25 | 2018-10-18 | PROCESS FOR THE PREPARATION OF BENZOTHIOPHEN-2YL BORONATE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20211268A1 true PE20211268A1 (es) | 2021-07-19 |
Family
ID=60293714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2020000736A PE20211268A1 (es) | 2017-10-25 | 2018-10-18 | Proceso para preparar el benzotiofen-2-il boronato |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11274110B2 (es) |
| EP (1) | EP3700894A1 (es) |
| JP (1) | JP2021500392A (es) |
| KR (1) | KR20200074128A (es) |
| CN (1) | CN111225907B (es) |
| AR (1) | AR113793A1 (es) |
| AU (1) | AU2018354780A1 (es) |
| BR (1) | BR112020008063A2 (es) |
| CA (1) | CA3084755A1 (es) |
| CL (1) | CL2020001093A1 (es) |
| CO (1) | CO2020004984A2 (es) |
| IL (1) | IL273952A (es) |
| JO (1) | JOP20200090A1 (es) |
| MX (1) | MX2020004285A (es) |
| PE (1) | PE20211268A1 (es) |
| SG (1) | SG11202002199RA (es) |
| TW (1) | TWI784074B (es) |
| UA (1) | UA126592C2 (es) |
| UY (1) | UY37949A (es) |
| WO (1) | WO2019081346A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4222167A1 (en) | 2020-09-30 | 2023-08-09 | Nobell Foods, Inc. | Recombinant milk proteins and food compositions comprising the same |
| US10894812B1 (en) | 2020-09-30 | 2021-01-19 | Alpine Roads, Inc. | Recombinant milk proteins |
| US10947552B1 (en) | 2020-09-30 | 2021-03-16 | Alpine Roads, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20030355A1 (it) * | 2003-07-18 | 2005-01-19 | Sigma Tau Ind Farmaceuti | Composti ad attivita' citotossica derivati della combretastatina. |
| JP2010518125A (ja) * | 2007-02-12 | 2010-05-27 | インターミューン・インコーポレーテッド | Ｃ型肝炎ウイルス複製の新規な阻害剤 |
| US20110201815A1 (en) * | 2008-10-15 | 2011-08-18 | Kissei Pharmaceutical Co., Ltd. | Fused heterocyclic derivative and use thereof for medical purposes |
| UY34484A (es) | 2011-12-15 | 2013-07-31 | Bayer Ip Gmbh | Benzotienilo-pirrolotriazinas disustituidas y sus usos |
| EP2791143B1 (en) * | 2011-12-15 | 2016-02-24 | Bayer Intellectual Property GmbH | Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment of cancer |
-
2018
- 2018-10-18 UA UAA202002884A patent/UA126592C2/uk unknown
- 2018-10-18 PE PE2020000736A patent/PE20211268A1/es unknown
- 2018-10-18 JP JP2020523692A patent/JP2021500392A/ja active Pending
- 2018-10-18 WO PCT/EP2018/078586 patent/WO2019081346A1/en unknown
- 2018-10-18 JO JOP/2020/0090A patent/JOP20200090A1/ar unknown
- 2018-10-18 AU AU2018354780A patent/AU2018354780A1/en not_active Abandoned
- 2018-10-18 SG SG11202002199RA patent/SG11202002199RA/en unknown
- 2018-10-18 BR BR112020008063-2A patent/BR112020008063A2/pt unknown
- 2018-10-18 KR KR1020207011684A patent/KR20200074128A/ko not_active Application Discontinuation
- 2018-10-18 US US16/759,139 patent/US11274110B2/en active Active
- 2018-10-18 MX MX2020004285A patent/MX2020004285A/es unknown
- 2018-10-18 EP EP18786350.1A patent/EP3700894A1/en not_active Withdrawn
- 2018-10-18 CN CN201880069634.9A patent/CN111225907B/zh active Active
- 2018-10-18 CA CA3084755A patent/CA3084755A1/en active Pending
- 2018-10-24 TW TW107137491A patent/TWI784074B/zh active
- 2018-10-25 AR ARP180103104A patent/AR113793A1/es unknown
- 2018-10-25 UY UY0001037949A patent/UY37949A/es not_active Application Discontinuation
-
2020
- 2020-04-13 IL IL273952A patent/IL273952A/en unknown
- 2020-04-23 CO CONC2020/0004984A patent/CO2020004984A2/es unknown
- 2020-04-23 CL CL2020001093A patent/CL2020001093A1/es unknown
-
2022
- 2022-03-10 US US17/691,858 patent/US20220356194A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018354780A1 (en) | 2020-04-09 |
| CN111225907A (zh) | 2020-06-02 |
| US11274110B2 (en) | 2022-03-15 |
| AR113793A1 (es) | 2020-06-10 |
| UA126592C2 (uk) | 2022-11-02 |
| RU2020115600A (ru) | 2021-11-25 |
| CN111225907B (zh) | 2023-05-26 |
| JP2021500392A (ja) | 2021-01-07 |
| RU2020115600A3 (es) | 2022-03-29 |
| TW201925211A (zh) | 2019-07-01 |
| WO2019081346A1 (en) | 2019-05-02 |
| US20220356194A1 (en) | 2022-11-10 |
| CO2020004984A2 (es) | 2020-05-05 |
| BR112020008063A2 (pt) | 2020-11-03 |
| JOP20200090A1 (ar) | 2020-05-03 |
| CA3084755A1 (en) | 2019-05-02 |
| EP3700894A1 (en) | 2020-09-02 |
| CL2020001093A1 (es) | 2020-10-23 |
| TWI784074B (zh) | 2022-11-21 |
| SG11202002199RA (en) | 2020-04-29 |
| KR20200074128A (ko) | 2020-06-24 |
| IL273952A (en) | 2020-05-31 |
| UY37949A (es) | 2019-05-31 |
| US20200339606A1 (en) | 2020-10-29 |
| MX2020004285A (es) | 2020-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500587A1 (en) | Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer | |
| CO2021008224A2 (es) | Inhibidores de kif18a | |
| PH12019501350A1 (en) | Amino-triazolopyridine compounds and their use in treating cancer | |
| TN2018000213A1 (en) | Compounds useful as kinase inhibitors | |
| PH12020550901A1 (en) | Macrocyclic compounds for treating disease | |
| CL2018001152A1 (es) | Composiciones y métodos para el tratamiento del cáncer | |
| CL2018001685A1 (es) | Compuestos heterociclicos como inmuno moduladores. | |
| MX2022005780A (es) | Moduladores de receptores estrogenicos. | |
| PE20180521A1 (es) | Inhibidores de tirosina-cinasas | |
| EA201990187A1 (ru) | Антипролиферационные средства на основе пиримидина | |
| CU20170029A7 (es) | Indazoles sustituidos con bencilo en calidad de inhibidores de bub1, útiles para el tratamiento o profilaxis de una enfermedad hiperproliferativa y/o un trastorno que responde a la inducción de la muerte celular, un procedimiento para la preparación de estos compuestos, y compuestos intermediarios | |
| CL2016001151A1 (es) | Derivados de purina 2,6-sustituidos y su uso en el tratamiento de trastorno proliferativos. | |
| MX2020006365A (es) | Quinazolinonas como inhibidores de poli(adenosin difosfato-ribosa)polimerasa 14 (parp14). | |
| PH12019502363A1 (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
| BR112017008039A2 (pt) | derivados de pirazol como inibidores de nik | |
| BR112017007715A2 (pt) | derivados de tienopirimidina como inibidores de nik | |
| EA201990400A1 (ru) | Соединения и композиции и их применение | |
| BR112017007704A2 (pt) | derivados de pirazolopirimidina como inibidores de nik | |
| PE20211268A1 (es) | Proceso para preparar el benzotiofen-2-il boronato | |
| EA201791249A1 (ru) | Получаемые из cd44v6 циклические пептиды для лечения злокачественных опухолей и связанных с ангиогенезом заболеваний | |
| MX2020003126A (es) | Derivados de iminopirimidina ciclicos como inhibidores de cinasa. | |
| MY176521A (en) | Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising the same and use thereof | |
| PH12017501122A1 (en) | Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof | |
| MX2020000636A (es) | Proteinas sinteticas y usos terapeuticos de las mismas. | |
| ECSP18000097A (es) | Inhibidores de tirosina-cinasas |